Citation Impact
Citing Papers
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
1998
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Complex organochlorine pesticide mixtures as determinant factor for breast cancer risk: a population-based case–control study in the Canary Islands (Spain)
2012
Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry
2000
Relationship of Epidermal Growth Factor Receptor Expression to ErbB-2 Signaling Activity and Prognosis in Breast Cancer Patients
2005
Comparative methodological analysis of erbB‐2/HER‐2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use
2000
Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk
2003
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies
2005
Impact of endocrine disruptor chemicals in gynaecology
2007
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Risk of female breast cancer and serum concentrations of organochlorine pesticides and polychlorinated biphenyls: A case–control study in Tunisia
2015
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
Microsatellite Instability in Colorectal Cancer
2010 Standout
Specificity of platinum–DNA adduct repair
1999
Strand-specific Mismatch Repair in Mammalian Cells
1997 StandoutNobel
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Molecular mechanisms of drug resistance
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Novel Vertebrate Genes and Putative Regulatory Elements Identified at Kidney Disease and NR2E1/fierce Loci
2002 StandoutNobel
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Alcohol and public health
2005 Standout
Environmental pollutants and breast cancer
2007
Endocrine Disruptors: Can Biological Effects and Environmental Risks Be Predicted?
2002
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
2005 StandoutNobel
Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study
2002
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features
2002 Standout
Ultrasound contrast agents: A review
1994
Epigenetics in Cancer
2008 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Human Exonuclease I Is Required for 5′ and 3′ Mismatch Repair
2002 StandoutNobel
Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin
1998
Exposure to pesticides and the associated human health effects
2016 Standout
DDT/DDE and breast cancer: A meta-analysis
2013
DNA Polymerase δ Is Required for Human Mismatch Repair in Vitro
1997 StandoutNobel
Cellular processing of platinum anticancer drugs
2005 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Organochlorines and Breast Cancer Risk
2002
CSF-1 and Its Receptor in Ovarian, Endometrial and Breast Cancer
1995
Organochlorines and Risk of Prostate Cancer
2003
Review of the epidemiologic literature on EMF and Health.
2001
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
1999
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Endocrine disruption of the epigenome: a breast cancer link
2014
Functions of MutLα, Replication Protein A (RPA), and HMGB1 in 5′-Directed Mismatch Repair
2009 StandoutNobel
CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract
1997
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Mechanism of 5′-Directed Excision in Human Mismatch Repair
2003 StandoutNobel
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin.
2001
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Breast Cancer Risk and the Combined Effect of Environmental Estrogens
2004
Review of the Epidemiologic Literature on EMF and Health
2001
Loss of DNA mismatch repair in acquired resistance to cisplatin.
1996
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction
1998
Assessment of the effect of percutaneous ethanol injection in autonomously functioning thyroid nodules by colour-coded duplex sonography
1995
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
2000
Ovarian Cancer
2008
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
Cellular and molecular pharmacology of oxaliplatin.
2002
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Associations of Serum Concentrations of Organochlorine Pesticides with Breast Cancer and Prostate Cancer in U.S. Adults
2009
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis.
2011
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York
2000
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p'-DDT, and p-p'-DDE, on methylnitrosourea-induced mammary tumor development in the rat.
2001
DDT and Breast Cancer in Young Women: New Data on the Significance of Age at Exposure
2007
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Recognition and Repair of Compound DNA Lesions (Base Damage and Mismatch) by Human Mismatch Repair and Excision Repair Systems
1997 StandoutNobel
The Role of CSF‐1 in Normal and Neoplastic Breast Physiology
1999
Works of D. Carter being referenced
Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours
1996
Tumor vascular signals in renal masses: detection with Doppler US.
1988
Microsatellite instability in ovarian neoplasms
1995
DDE and DDT in Breast Adipose Tissue and Risk of Female Breast Cancer
1999
Exposure to Electromagnetic Fields from Use of Electric Blankets and Other In-Home Electrical Appliances and Breast Cancer Risk
2000
Oxychlordane and trans-nonachlor in breast adipose tissue and risk of female breast cancer.
2000
Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene.
2000
Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.
1990